Clinical Trial Update: Xpede Clinical Study [NA]

View source ↗

Summary

Completed clinical trial update for Xpede in vertebral fracture conditions with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pathological Fracture of Vertebra Due to Neoplastic Disease
• Pathological Fracture of Vertebra Due to Secondary Osteoporosis

Drugs mentioned

• Xpede

Snippet

Sponsor: Medtronic Spinal and Biologics | Conditions: Pathological Fracture of Vertebra Due to Secondary Osteoporosis (Disorder), Pathological Fracture of Vertebra Due to Neoplastic Disease (Disorder) | NA | Status: COMPLETED | Results posted: 2023-01-10